SIGA’S SMALLPOX WIN IS NO MONKEY BUSINESS!

  $SIGA   Siga Technologies (NASDAQ: SIGA), a commercial-stage pharmaceutical company scored an FDA approval for its intravenous (IV) formulation of TPOXX® (tecovirimat) by the U...read more